500-facility MediMate247 claim puts DHA, DOH and MOHAP proof ahead of price

MediMate247 says more than 500 UAE healthcare facilities use its EMR/EHR platform, putting regulator connectivity at the center of any buyer review.

The claim appeared in a 15 June 2026 press-release listing in The National Law Review. For UAE clinic groups, the first question is practical: can the system prove live connectivity with Dubai Health Authority (DHA), Department of Health Abu Dhabi (DOH) and Ministry of Health and Prevention (MOHAP) systems before a contract is signed?

What MediMate247 is claiming

MediMate247 markets itself as a combined EMR, billing, insurance, pharmacy, laboratory and radiology system. Its buyer guide says pricing starts at AED 3,000 annually, a level that will draw attention from small clinics that cannot absorb enterprise EMR implementation costs.

"MediMate247 emerges as the UAE's most trusted all-in-one EMR/EHR." The National Law Review press-release headline, 15 June 2026

That wording is vendor positioning. The cited material does not include an independent UAE market-share table, audited user count or customer-retention figure. CIOs should ask for three documents before procurement: a current NABIDH certification letter, a Malaffi integration reference and a Riayati connectivity statement.

Why the claim matters for operators

EMR selection in the UAE now sits inside a regulator-connectivity test. DHA runs NABIDH, DOH oversees Malaffi, and MOHAP runs Riayati for the national medical record. For operators, an EMR contract can affect compliance, claims, workflow and clinical risk.

• DHA NABIDH: more than 1,300 Dubai facilities connected and more than 9.47 million patient records unified, according to Kyndryl's 2024 update on the DHA programme.
• DOH Malaffi: more than 2,700 Abu Dhabi facilities connected, according to DOH's Malaffi page.
• MOHAP Riayati: more than 2,500 healthcare facilities linked across public and private providers, according to MOHAP.
• MediMate247: more than 500 healthcare facilities claimed by the vendor in the 15 June 2026 release.

For multi-emirate groups, one platform must handle local variation. A Dubai clinic needs DHA and NABIDH readiness. An Abu Dhabi clinic needs DOH and Malaffi readiness. A Northern Emirates site needs MOHAP and Riayati readiness. A vendor that works in one emirate may still require integration work in the other 6 emirates.

What buyers should test first

The press-release format makes the announcement useful but limited. Operators should treat 15 June 2026 as the start of diligence. A low annual licence can become expensive if a clinic later pays for data mapping, insurer workflows or regulatory remediation.

The practical benchmark is implementation evidence. Ask for 2 UAE customer references in the same specialty, a sample migration plan, a security incident process and written support hours. If MediMate247 cites NABIDH, Malaffi or Riayati, ask whether the integration is live, certified, pending or routed through a partner.

The buyer takeaway is direct: remember 500 facilities, but verify 3 regulator links. If MediMate247 can show current approvals, stable claims workflows and UAE support for small and mid-sized providers, it can compete for clinics priced out of larger hospital systems. Without that proof, CIOs and COOs should treat the claim as marketing in a market where DHA, DOH and MOHAP compliance is the buying threshold.